We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

140 hedge funds and large institutions have $92.8M invested in Viking Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $637K

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

0% more funds holding

Funds holding: 140 → 140 (0)

6.66% less ownership

Funds ownership: 46.27% → 39.61% (-6.7%)

44% less capital invested

Capital invested by funds: $166M → $92.8M (-$73.5M)

Holders
140
Holders Change
–
Holders Change %
0%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
46
Reduced
34
Closed
19
Calls
$1.06M
Puts
$637K
Net Calls
+$425K
Net Calls Change
-$1.77M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.65M
2
PWAM
Park West Asset Management
California
+$3.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.25M
5
SCM
Sio Capital Management
New York
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$25.3M
2
State Street
State Street
Massachusetts
-$9.93M
3
N
Nuveen
North Carolina
-$1.88M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.05M
5
UBS Group
UBS Group
Switzerland
-$918K
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
126
Montag & Associates
Georgia
$2K – – –
Northwestern Mutual Wealth Management
127
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
Toronto Dominion Bank
128
Toronto Dominion Bank
Ontario, Canada
$2K +$2.49K +693 New
CAPTRUST Financial Advisors
129
CAPTRUST Financial Advisors
North Carolina
$2K +$2.85K +795 New
TWA
130
TCI Wealth Advisors
Arizona
$1K -$3.01K -840 -74%
GWM
131
Geneos Wealth Management
Colorado
$1K – – –
SSB
132
Sandy Spring Bank
Maryland
$1K – – –
QCG
133
Quadrant Capital Group
Ohio
$1K +$994 +277 +1,108%
Macquarie Group
134
Macquarie Group
Australia
$996 – – –
TWC
135
TD Waterhouse Canada
Ontario, Canada
$219 – – –
Rafferty Asset Management
136
Rafferty Asset Management
New York
– -$1.05M -229,119 Closed
Ameriprise
137
Ameriprise
Minnesota
– -$485K -105,464 Closed
AI
138
Atom Investors
Texas
– -$431K -93,636 Closed
CCIA
139
Campbell & Co Investment Adviser
Maryland
– -$247K -53,600 Closed
M&T Bank
140
M&T Bank
New York
– -$132K -28,648 Closed
AGM
141
Alpine Global Management
New York
– -$123K -26,775 Closed
XT
142
XTX Topco
Cayman Islands
– -$89K -19,363 Closed
TI
143
Trexquant Investment
Connecticut
– -$86K -18,714 Closed
Wolverine Trading
144
Wolverine Trading
Illinois
– -$58.3K -16,250 Closed
9WM
145
9258 Wealth Management
Ohio
– -$66K -14,379 Closed
DU
146
Delphia (USA)
Ontario, Canada
– -$62K -13,468 Closed
VF
147
Virtu Financial
New York
– -$58K -12,633 Closed
FRM
148
Fox Run Management
Connecticut
– -$52K -11,199 Closed
LC
149
Lindbrook Capital
California
– -$35K -7,500 Closed
SCA
150
Snowden Capital Advisors
New York
– -$11K -2,400 Closed
3 4 5
6
7

VKTX Hedge Fund Activity: Q1 2022 in Review

140 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2022, worth a combined $92.8M — down 44% from $166M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VKTX positions and 19 closed out — a net gain of 2 holders — while 46 added to existing stakes and 34 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.65M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $25.3M.

  • 140 institutional investors held Viking Therapeutics (VKTX) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $92.8M of Viking Therapeutics stock for Q1 2022, down 44% quarter-over-quarter.
  • 21 funds opened new Viking Therapeutics positions in Q1 2022 and 19 closed out, a net change of +2 holders.
  • The largest Viking Therapeutics buyer in Q1 2022 was Millennium Management, an estimated $4.65M added.
  • The largest Viking Therapeutics seller in Q1 2022 was ArrowMark Colorado Holdings, an estimated $25.3M sold.

Based on aggregated 13F filings for Q1 2022.